enGene Therapeutics Inc. (ENGN): SCHEDULE 13G/A filed Aug 12, 2026

Form type

SCHEDULE 13G/A

Filing date

Aug 12, 2026

Accession number

0001140361-26-032512

Filer

enGene Therapeutics Inc. (CIK 1980845)